Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 5816960, 16 pages
https://doi.org/10.1155/2017/5816960
Research Article

Beneficial Effects of Paeoniflorin Enriched Extract on Blood Pressure Variability and Target Organ Damage in Spontaneously Hypertensive Rats

1Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China
2Zhejiang University of Technology, Hangzhou, Zhejiang 310014, China
3Zhejiang Academy of Medical Sciences, Hangzhou 310053, China
4Wenzhou Medical University, Wenzhou, Zhejiang 325035, China

Correspondence should be addressed to Su-Hong Chen; nc.ude.tujz@gnohusnehc and Gui-Yuan Lv; moc.361@yglmctjz

Received 30 October 2016; Accepted 20 December 2016; Published 24 January 2017

Academic Editor: Waris Qidwai

Copyright © 2017 Bo Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Primatesta and N. R. Poulter, “Improvement in hypertension management in England: results from the Health Survey for England 2003,” Journal of Hypertension, vol. 24, no. 6, pp. 1187–1192, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. P. M. Kearney, M. Whelton, K. Reynolds, P. Muntner, P. K. Whelton, and J. He, “Global burden of hypertension: analysis of worldwide data,” The Lancet, vol. 365, no. 9455, pp. 217–223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Cai, L. Zhang, A. Liu, S. Li, and P. Wang, “Prevalence, awareness, treatment, and control of hypertension among adults in Beijing, China,” Clinical & Experimental Hypertension, vol. 19, no. 2, pp. 159–168, 2012. View at Google Scholar
  4. G. Parati, G. Pomidossi, F. Albini, D. Malaspina, and G. Mancia, “Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension,” Journal of Hypertension, vol. 5, no. 1, pp. 93–98, 1987. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Zhang, Y. Cheng, and D. Wang, “Circadian profiles of blood pressure and blood pressure variability in spontaneous hypertensive rats,” Journal of Clinical Cardiology, vol. 12, no. 4, pp. 239–241, 1996. View at Google Scholar
  6. D.-F. Su and C.-Y. Miao, “Reduction of blood pressure variability: a new strategy for the treatment of hypertension,” Trends in Pharmacological Sciences, vol. 26, no. 8, pp. 388–390, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. M.-C. Irigoyen, K. De Angelis, F. dos Santos, D. R. Dartora, B. Rodrigues, and F. M. Consolim-Colombo, “Hypertension, blood pressure variability, and target organ lesion,” Current Hypertension Reports, vol. 18, no. 4, article 31, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Xiong and Y. Wang, “Simultaneous determination of paeoniflorin from total glucosides of paeony in Sprague-Dawley rats and spontaneously hypertensive rats by high-performance liquid chromatography-tandem mass spectrometry: in vivo and in vitro studies,” Biomedical Chromatography, vol. 30, no. 11, pp. 1766–1771, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. S. N. Jin, J. F. Wen, T. T. Wang, D. G. Kang, H. S. Lee, and K. W. Cho, “Vasodilatory effects of ethanol extract of Radix Paeoniae Rubra and its mechanism of action in the rat aorta,” Journal of Ethnopharmacology, vol. 142, no. 1, pp. 188–193, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Qian, J. Cao, C. Chen et al., “Paeoniflorin inhibits pulmonary artery smooth muscle cells proliferation via upregulating A2B adenosine receptor in rat,” PLoS ONE, vol. 8, no. 7, Article ID e69141, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. R.-B. Guo, G.-F. Wang, A.-P. Zhao, J. Gu, X.-L. Sun, and G. Hu, “Paeoniflorin protects against ischemia-induced brain damages in rats via inhibiting MAPKs/NF-κB-mediated inflammatory responses,” PLoS ONE, vol. 7, no. 11, Article ID e49701, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. Z. X. Peng, H. D. Huang, and S. G. Deng, “Effects of paeoniflorin on isolated thoracic aorta rings of rats and its possible mechanism,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 17, no. 7, pp. 190–193, 2011. View at Google Scholar
  13. L. Han, X. H. Zhou, W. W. Wang, and C. X. Chen, “Experimental researches of glucosides of radix paeoniae alba on reversing myocardial remodeling induced by different drugs,” Journal of Liaoning University of Traditional Chinese Medicine, vol. 13, no. 2, pp. 43–48, 2011. View at Google Scholar
  14. J.-T. Cheng, C.-J. Wang, and F.-L. Hsu, “Paeoniflorin reverses guanethidine-induced hypotension via activation of central adenosine A1 receptors in wistar rats,” Clinical & Experimental Pharmacology & Physiology, vol. 26, no. 10, pp. 815–816, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Su-Hong, C. Qi, L. Bo, G. Jian-Li, S. Jie, and L. Gui-Yuan, “Antihypertensive effect of radix paeoniae alba in spontaneously hypertensive rats and excessive alcohol intake and high fat diet induced hypertensive rats,” Evidence-based Complementary and Alternative Medicine, vol. 2015, Article ID 731237, 8 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. Q. Chen, S. H. Chen, and G. Y. Lv, “Effects of herbaceous peony extract on blood pressure,blood lipid levels and hepatic function of aged apontaneously hypertensive rats,” Journal of Zhejiang Chinese Medical University, vol. 37, no. 2, pp. 187–191, 2013. View at Google Scholar
  17. B. N. Van Vliet, J. McGuire, L. Chafe, A. Leonard, A. Joshi, and J.-P. Montani, “Phenotyping the level of blood pressure by telemetry in mice,” Clinical & Experimental Pharmacology & Physiology, vol. 33, no. 11, pp. 1007–1015, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Gillis, J. Mooney, M. Garrett, and J. Sasser, “Sildenafil treatment improves the maternal syndrome in the preeclamptic Dahl salt sensitive (s) rat,” International Journal of Gynecological Cancer, vol. 20, no. 7, pp. 1197–1200, 2010. View at Google Scholar
  19. Z.-Z. Shan, S.-M. Dai, F. Fang, and D.-F. Su, “Cardiovascular and renal morphological changes in sinoaortic denervated rats,” Chinese Journal of Pharmacology & Toxicology, vol. 17, no. 2, pp. 100–105, 2003. View at Google Scholar · View at Scopus
  20. A. J. Webb, U. Fischer, Z. Mehta, and P. M. Rothwell, “Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis,” The Lancet, vol. 375, no. 9718, pp. 906–915, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Parati, J. E. Ochoa, C. Lombardi, and G. Bilo, “Assessment and management of blood-pressure variability,” Nature Reviews Cardiology, vol. 11, no. 6, pp. 143–155, 2014. View at Google Scholar
  22. X. Zhang and Q. Zhang, “Preliminary study of blood pressure variability (BPV) and target organ damage in elderly hypertension,” International Journal of Cardiology, vol. 152, pp. S20–S21, 2011. View at Publisher · View at Google Scholar
  23. S. Shibasaki, S. Hoshide, and K. Kario, “Within-home blood pressure variability on a single occasion has clinical significance,” Pulse, vol. 4, no. 1, pp. 38–42, 2016. View at Publisher · View at Google Scholar
  24. U. Fischer, A. J. S. Webb, S. C. Howard, and P. M. Rothwell, “Reporting of consistency of blood pressure control in randomized controlled trials of antihypertensive drugs: a systematic review of 1372 trial reports,” Journal of Hypertension, vol. 30, no. 7, pp. 1271–1276, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. D.-F. Su and C.-Y. Miao, “Blood pressure variability and organ damage,” Clinical and Experimental Pharmacology and Physiology, vol. 28, no. 9, pp. 709–715, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Magyar, L. Deres, K. Eros et al., “A quinazoline-derivative compound with PARP inhibitory effect suppresses hypertension-induced vascular alterations in spontaneously hypertensive rats,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1842, no. 7, pp. 935–944, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. J.-X. Zhang, J.-R. Yang, G.-X. Chen et al., “Sesamin ameliorates arterial dysfunction in spontaneously hypertensive rats via downregulation of NADPH oxidase subunits and upregulation of eNOS expression,” Acta Pharmacologica Sinica, vol. 34, no. 7, pp. 912–920, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. K.-T. Kang, “Endothelium-derived relaxing factors of small resistance arteries in hypertension,” Toxicological Research, vol. 30, no. 3, pp. 141–148, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Perrino, S. V. Naga Prasad, L. Mao et al., “Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction,” Journal of Clinical Investigation, vol. 116, no. 6, pp. 1547–1560, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Martinka, J. Fielitz, A. Patzak, V. Regitz-Zagrosek, P. B. Persson, and H. M. Stauss, “Mechanisms of blood pressure variability-induced cardiac hypertrophy and dysfunction in mice with impaired baroreflex,” American Journal of Physiology - Regulatory Integrative and Comparative Physiology, vol. 288, no. 3, pp. R767–R776, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Frattola, G. Parati, C. Cuspidi, F. Albini, and G. Mancia, “Prognostic value of 24-hour blood pressure variability,” Journal of Hypertension, vol. 11, no. 10, pp. 1133–1137, 1993. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Tatasciore, M. Zimarino, R. Tommasi et al., “Increased short-term blood pressure variability is associated with early left ventricular systolic dysfunction in newly diagnosed untreated hypertensive patients,” Journal of Hypertension, vol. 31, no. 8, pp. 1653–1661, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Ryu, R.-H. Cha, D. K. Kim et al., “The clinical association of the blood pressure variability with the target organ damage in hypertensive patients with chronic kidney disease,” Journal of Korean Medical Science, vol. 29, no. 7, pp. 957–964, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Leoncini, F. Viazzi, G. Storace, G. Deferrari, and R. Pontremoli, “Blood pressure variability and multiple organ damage in primary hypertension,” Journal of Human Hypertension, vol. 27, no. 11, pp. 663–670, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. M. F. Hussein, A. H. Al-Mashhadani, and S. I. Essa, “The use of left ventricular myocardial stiffness index as a predictor of myocardial performance in patients with systemic hypertension,” International Journal of Medical Physics, Clinical Engineering and Radiation Oncology, vol. 3, no. 3, pp. 167–175, 2014. View at Publisher · View at Google Scholar
  36. W. B. Zhang, Q. J. Du, H. Li et al., “The therapeutic effect of Rosuvastatin on cardiac remodelling from hypertrophy to fibrosis during the end-stage hypertension in rats,” Journal of Cellular & Molecular Medicine, vol. 16, no. 9, pp. 2227–2237, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Yan, J. D. Zhang, B. Wang et al., “Quercetin inhibits left ventricular hypertrophy in spontaneously hypertensive rats and inhibits angiotensin II-induced H9C2 cells hypertrophy by enhancing PPAR-γ expression and suppressing AP-1 activity,” PLOS ONE, vol. 8, no. 9, Article ID e72548, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. H. A. Baba and J. Wohlschlaeger, “Morphological and molecular changes of the myocardium after left ventricular mechanical support,” Current Cardiology Reviews, vol. 4, no. 3, pp. 157–169, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Qian, P. Zhong, D. Liang et al., “A newly designed curcumin analog Y20 mitigates cardiac injury via anti-inflammatory and anti-oxidant actions in obese rats,” PLoS ONE, vol. 10, no. 3, Article ID e0120215, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. T. A. Samad, K. A. Moore, A. Sapirstein et al., “Interleukin-1 β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity,” Nature, vol. 410, no. 6827, pp. 471–475, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. R.-B. Guo, G.-F. Wang, A.-P. Zhao, J. Gu, X.-L. Sun, and G. Hu, “Paeoniflorin protects against ischemia-induced brain damages in rats via inhibiting MAPKs/NF-κB-Mediated inflammatory responses,” PLoS ONE, vol. 7, no. 11, Article ID e49701, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. Z. Jia and J. He, “Paeoniflorin ameliorates rheumatoid arthritis in rat models through oxidative stress, inflammation and cyclooxygenase 2,” Experimental and Therapeutic Medicine, vol. 11, no. 2, pp. 655–659, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Chen, J. Yin, Y. Deng et al., “The protective effects of ginsenoside Rg1 against hypertension target-organ damage in spontaneously hypertensive rats,” BMC Complementary & Alternative Medicine, vol. 12, article no. 53, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Tian, S. Ling, G. Chen et al., “Hypertensive nephropathy treatment by heart-protecting musk pill: a study of anti-inflammatory therapy for target organ damage of hypertension,” International Journal of General Medicine, vol. 4, pp. 131–139, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Palatini, “Day-by-day blood pressure variability: cause or consequence of vascular brain injury?” Hypertension, vol. 63, no. 6, pp. 1163–1165, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Kaiser, G. Weise, K. Möller et al., “Spontaneous white matter damage, cognitive decline and neuroinflammation in middle-aged hypertensive rats: an animal model of early-stage cerebral small vessel disease,” Acta neuropathologica communications, vol. 2, article 169, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Liu, J. Wang, J. Wang, P. Wang, and Y. Xue, “Paeoniflorin attenuates Aβ1-42-induced inflammation and chemotaxis of microglia in vitro and inhibits NF-κB- and VEGF/Flt-1 signaling pathways,” Brain Research, vol. 1618, pp. 149–158, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. H.-R. Zhang, J.-H. Peng, X.-B. Cheng, B.-Z. Shi, M.-Y. Zhang, and R.-X. Xu, “Paeoniflorin atttenuates amyloidogenesis and the inflammatory responses in a transgenic mouse model of Alzheimer’s disease,” Neurochemical Research, vol. 40, no. 8, pp. 1583–1592, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. J.-Y. Wang, H. Li, C.-M. Ma, J.-L. Wang, X.-S. Lai, and S.-F. Zhou, “MicroRNA profiling response to acupuncture therapy in spontaneously hypertensive rats,” Evidence-based Complementary and Alternative Medicine, vol. 2015, Article ID 204367, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. G. Luo, X. Zhu, Z. Gao et al., “Effects of Yishen Pinggan Recipe on renal protection and NF-κB signaling pathway in spontaneously hypertensive rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2016, Article ID 6435040, 7 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Rubattu, S. Di Castro, M. Cotugno et al., “Protective effects of Brassica oleracea sprouts extract toward renal damage in high-salt-fed SHRSP: role of AMPK/PPARα/UCP2 axis,” Journal of Hypertension, vol. 33, no. 7, pp. 1465–1479, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. B. Mell, V. R. Jala, A. V. Mathew et al., “Evidence for a link between gut microbiota and hypertension in the Dahl rat,” Physiological Genomics, vol. 47, no. 6, pp. 187–197, 2015. View at Publisher · View at Google Scholar · View at Scopus
  53. E. Oliveirasales, E. Maquigussa, V. Varela et al., “Mesenchymal stem cells (MSC) improve both stenotic and contralateral kidneys in the renovascular hypertension,” The FASEB Journal, vol. 29, no. 1, pp. 960–975, 2015. View at Google Scholar
  54. M. Zhou, L. Mao, Y. Wang et al., “Morphologic changes of cerebral veins in hypertensive rats: venous collagenosis is associated with hypertension,” Journal of Stroke & Cerebrovascular Diseases, vol. 24, no. 3, pp. 530–536, 2015. View at Publisher · View at Google Scholar · View at Scopus
  55. M. R. Bersi, C. Bellini, J. Wu, K. R. C. Montaniel, D. G. Harrison, and J. D. Humphrey, “Excessive adventitial remodeling leads to early aortic maladaptation in angiotensin-induced hypertension,” Hypertension, vol. 67, no. 5, pp. 890–896, 2016. View at Publisher · View at Google Scholar · View at Scopus
  56. S. A. Sadek, L. A. Rashed, A. M. Bassam, and E. S. Said, “Effect of aliskiren, telmisartan and torsemide on cardiac dysfunction in l-nitro arginine methyl ester (l-NAME) induced hypertension in rats,” Journal of Advanced Research, vol. 6, no. 6, pp. 967–974, 2015. View at Publisher · View at Google Scholar · View at Scopus
  57. Q. Zhang, G. Y. Lv, C. Q. Xia et al., “A novel hypertensive rat model induced by long-term high-purine diet,” Pharmacology & Clinics of Chinese Materia Medica, vol. 29, no. 1, pp. 159–162, 2013. View at Google Scholar
  58. C. Q. Xia, G. Y. Lv, S. H. Chen et al., “Effect of long-term high glucose and lysophosphatidylcholine diet on blood pressure, liver and kidney function in rats,” Pharmacology & Clinics of Chinese Materia Medica, vol. 28, no. 3, pp. 122–124, 2012. View at Google Scholar
  59. K. Okamoto and K. Aoki, “Development of a strain of spontaneously hypertensive rats,” Japanese circulation journal, vol. 27, no. 3, pp. 282–293, 1963. View at Publisher · View at Google Scholar · View at Scopus
  60. E. M. Krieger, “Neurogenic hypertension in the rat,” Circulation Research, vol. 15, no. 6, pp. 511–521, 1964. View at Publisher · View at Google Scholar · View at Scopus
  61. J. S. del Mauro, Y. Santander, F. M. Bertera et al., “Effects of chronic carvedilol administration on blood pressure variability and target organ injury in rats with sinoaortic denervation,” Revista Argentina De Cardiologia, vol. 83, no. 3, pp. 181–186, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. L. Hong, C. S. Xiao, L. Wang et al., “Changes of ambulatory blood pressure and morphology of resistance vessel in spontaneously hypertensive rats at different weeks of ages,” Chinese Journal of Pathophysiology, vol. 27, no. 4, pp. 653–657, 2011. View at Google Scholar
  63. L. Z. Zhang, S. Z. Pan, W. M. Zhou et al., “Study on dynamic changes and gender difference of heart rate variability and blood pressure variability via implantable telemetry technology in spontaneously hypertensive rats,” Chinese Journal of Comparative Medicine, vol. 25, no. 1, pp. 15–19, 2015. View at Google Scholar
  64. B. Schmelting, M. Niehoff, B. Egner, S. H. Korte, and G. F. Weinbauer, “High definition oscillometry: a novel technique for non-invasive blood pressure monitoring in the cynomolgus monkey (Macaca fascicularis),” Journal of Medical Primatology, vol. 38, no. 5, pp. 293–301, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. J. A. Potkay, “Long term, implantable blood pressure monitoring systems,” Biomedical Microdevices, vol. 10, no. 3, pp. 379–392, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. H. Kai, H. Kudo, N. Takayama, S. Yasuoka, Y. Aoki, and T. Imaizumi, “Molecular mechanism of aggravation of hypertensive organ damages by short-term blood pressure variability,” Current Hypertension Reviews, vol. 10, no. 3, pp. 125–133, 2014. View at Google Scholar · View at Scopus
  67. C.-H. Chen and M.-H. Shyr, “Blockade of spinal nitric oxide synthase on blood pressure variability and hepatic microcirculation,” Acta Anaesthesiologica Taiwanica, vol. 43, no. 2, pp. 67–72, 2005. View at Google Scholar · View at Scopus